LYNDSI SIMMONS: Open Payments
NPI 1730844747 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 124 payments from 18 companies in 2025. Trend: 2023 $1,594 · 2024 $1,020 · 2025 $1,792
Food & beverage: $1,792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $517 |
| Novo Nordisk Inc | 22 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $285 |
| PFIZER INC. | 10 | $151 |
| Otsuka America Pharmaceutical, Inc. | 8 | $135 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Exact Sciences Corporation | 2 | $43 |
| Lilly USA, LLC | 3 | $43 |
| Corium, LLC | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: CAPLYTA, VRAYLAR, Ozempic, REXULTI, UBRELVY, NURTEC ODT, Wegovy, QULIPTA.
Industry payments across IN — which companies pay providers there.
